Humanized CD19 CAR-T Cells With TLR2

CD19-directed CAR-T cells with TLR2 co-stimulation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Humanized CD19 CAR-T Cells With TLR2, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy [EARLY_Phase 1]

See pricing